Lipoprotein glomerulopathy induced by ApoE Kyoto mutation in ApoE-deficient mice

被引:12
|
作者
Wu, Hongyan [1 ,2 ]
Yang, Jing [1 ,2 ]
Liu, Yun-Qiang [3 ]
Lei, Song [4 ]
Yang, Mei [4 ]
Yang, Zhi [1 ,2 ]
Yang, Yuan [3 ]
Hu, Zhangxue [1 ,2 ]
机构
[1] Sichuan Univ, Dept Nephrol, West China Hosp, Guoxue Alley,37, Chengdu 610041, Sichuan, Peoples R China
[2] Sichuan Univ, Natl Clin Res Ctr Geriatr, West China Hosp, Guoxue Alley,37, Chengdu 610041, Sichuan, Peoples R China
[3] Sichuan Univ, Dept Med Genet, West China Hosp, Chengdu, Peoples R China
[4] Sichuan Univ, West China Hosp, Dept Pathol, Chengdu, Peoples R China
基金
中国国家自然科学基金;
关键词
Lipoprotein glomerulopathy; ApoE Kyoto (p; R43C); ApoE Sendai (p; R163P); Atherosclerosis; Recombinant adenovirus;
D O I
10.1186/s12967-021-02765-x
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background Lipoprotein glomerulopathy (LPG) is a rare autosomal dominant kidney disease that is most commonly caused by mutations in ApoE Kyoto (p.R43C) and ApoE Sendai (p.R163P). Differences in phenotype among the various ApoE mutations have been suggested, but the pathogenic role of ApoE Kyoto has not been validated in an animal model. This study intended to establish an ApoE Kyoto murine model and to further compare the pathologic differences between ApoE Kyoto and ApoE Sendai. Method Male ApoE-deficient mice, 3 months of age, were divided into five groups, including the AD-ApoE Sendai, AD-ApoE Kyoto, AD-ApoE3, AD-eGFP, and ApoE (-/-) groups. The first four groups received recombinant adenovirus that contained the entire coding regions of the human ApoE Sendai and ApoE Kyoto, apoE3, and eGFP genes, respectively. Fasting blood and urine samples were collected at multiple time points. Lipid profiles and urine albumin-creatinine ratio were measured. Renal and aortic histopathologic alterations were analyzed. Results After virus injection, plasma human ApoE was detected and rapidly reached the maximum level at 4-6 days in the AD-ApoE Kyoto and AD-ApoE Sendai groups (17.4 +/- 3.1 mu g/mL vs.: 22.2 +/- 4.5 mu g/mL, respectively) and at 2 days in the AD-ApoE3 group (38.4 mu g/mL). The serum total cholesterol decreased by 63%, 65%, and 73% in the AD-ApoE Kyoto, AD-ApoE Sendai and AD-ApoE3 groups, respectively. There were no significant changes in serum triglyceride and urinary albumin-creatinine ratio among the five groups. Typical lipoprotein thrombi with positive ApoE staining were detected in the AD-ApoE Kyoto and AD-ApoE Sendai groups. The Oil-red O-positive glomerular area tended to be higher in the AD-ApoE Kyoto group (9.2%) than in the AD-ApoE Sendai (3.9%), AD-ApoE3 (4.8%), AD-eGFP (2.9%), and ApoE (-/-) (3.6%) groups. The atherosclerotic plaque area in the aorta was lower in the group injected with various ApoE mutations than in the group without injection of ApoE mutation. Conclusions In this animal study, we first established an ApoE Kyoto mutation murine model and confirmed its pathogenic role in LPG. Our results suggested that LPG may be more severe with the ApoE Kyoto than with the ApoE Sendai.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Immunization prevents infection-induced acceleration of atherosclerosis in ApoE-Deficient mice
    Gibson, FC
    Hong, C
    Wong, J
    Yumoto, H
    Genco, CA
    CIRCULATION, 2003, 108 (17) : 129 - 129
  • [32] Complete atherosclerosis regression after human ApoE gene transfer in ApoE-deficient/nude mice
    Desurmont, C
    Caillaud, JM
    Emmanuel, F
    Benoit, P
    Fruchart, JC
    Castro, G
    Branellec, D
    Heard, JM
    Duverger, N
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (02) : 435 - 442
  • [33] The Role of TLR signaling in the development of emphysema in ApoE-deficient mice
    Golovatch, P.
    Mehra, D.
    Lemaitre, V.
    D'Armiento, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
  • [34] Near infrared imaging of lesion formation in ApoE-deficient mice
    Dietrich, T.
    Tachezy, M.
    Stawowy, P.
    Graefe, M.
    Licha, K.
    Hauff, P.
    Schirner, M.
    Fleck, E.
    Graf, K.
    EUROPEAN HEART JOURNAL, 2007, 28 : 113 - 113
  • [35] Diminazene enhances stability of atherosclerotic plaques in ApoE-deficient mice
    Fraga-Silva, Rodrigo A.
    Montecucco, Fabrizio
    Costa-Fraga, Fabiana P.
    Nencioni, Alessio
    Caffa, Irene
    Bragina, Maiia E.
    Mach, Francois
    Raizada, Mohan K.
    Santos, Robson A. S.
    da Silva, Rafaela F.
    Stergiopulos, Nikolaos
    VASCULAR PHARMACOLOGY, 2015, 74 : 103 - 113
  • [36] Rapid development of vein graft atheroma in ApoE-deficient mice
    Dietrich, H
    Hu, YH
    Zou, YP
    Huemer, U
    Metzler, B
    Li, CH
    Mayr, M
    Xu, QB
    AMERICAN JOURNAL OF PATHOLOGY, 2000, 157 (02): : 659 - 669
  • [37] Valproate Attenuates Accelerated Atherosclerosis in Hyperglycemic ApoE-Deficient Mice
    Bowes, Anna J.
    Khan, Mohammad I.
    Shi, Yuanyuan
    Robertson, Lindsie
    Werstuck, Geoff H.
    AMERICAN JOURNAL OF PATHOLOGY, 2009, 174 (01): : 330 - 342
  • [38] Anti-atherosclerotic effect of sinigrin in ApoE-deficient mice
    Jang, Yeon Jeong
    Pyo, Suhkneung
    FASEB JOURNAL, 2015, 29
  • [39] MnSOD deficiency increases endothelial dysfunction in ApoE-deficient mice
    Ohashi, Masuo
    Runge, Marschall S.
    Faraci, Frank M.
    Heistad, Donald D.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (10) : 2331 - 2336
  • [40] A founder haplotype of APOE-Sendai mutation associated with lipoprotein glomerulopathy
    Toyota, Kentaro
    Hashimoto, Taeko
    Ogino, Daisuke
    Matsunaga, Akira
    Ito, Minoru
    Masakane, Ikuto
    Degawa, Noriyuki
    Sato, Hiroshi
    Shirai, Sayuri
    Umetsu, Kazuo
    Tamiya, Gen
    Saito, Takao
    Hayasaka, Kiyoshi
    JOURNAL OF HUMAN GENETICS, 2013, 58 (05) : 254 - 258